In addition to activating T and B lymphocytes, interleukin 1 (IL-1) induces several hematologic and metabolic changes typical of host responses to infection and injury. We now report a new biological property, namely, the induction of hypotension. Rabbits given a single intravenous injection of recombinant human IL-I-beta (5 isg/kg) rapidly developed decreased systemic arterial pressure, which reached the lowest levels after 50-60 min and slowly returned to pre-IL-I values after 3 h. Associated with the hypotension, systemic vascular resistance and central venous pressure fell, while cardiac output and heart rate increased. These responses were prevented by ibuprofen given 15 min before the IL-i. A bolus injection of IL-I followed by a 2-h infusion sustained the hypotension and was associated with leukopenia and thrombocytopenia. Ibuprofen given at the mid-point of the infusion reversed the changes in all hemodynamic parameters, but had no effect on the leukopenia or thrombocytopenia. Tumor necrosis factor (TNF) also induced a shock-like state in rabbits. When the dose of IL-1 or TNF was reduced to 1 ,ug/kg, no hemodynamic changes were observed; however, the combination of these low doses of both cytokines resulted in a profound shock-like state including histological evidence of severe pulmonary edema and hemorrhage. Pretreatment with ibuprofen prevented the hemodynamic, leukocyte, and platelet changes induced by the low-dose cytokine combination, and ameliorated the pulmonary tissue damage.
Introduction
The polypeptide interleukin 1 (IL-1) mediates several systemic changes associated with infection and injury such as fever, neutrophilia, increased hepatic acute phase protein synthesis, hypoferremia, and elevated corticosteroid levels (1) (2) (3) . Recombinant IL-1 (beta or alpha forms) have confirmed earlier studies that implicated IL-I as an important mediator of these and other acute phase responses, as well as being an immunologically active molecule (4) . The synthesis and release of IL-I from macrophages and other cell types are initiated by microorganisms, endotoxins or exotoxins from a variety ofbacteria, or tissue injury. There are two distinct genes coding for IL-1: compared with IL-l-alpha (5), IL-l-beta is the predominant IL-1 and a major product of human monocytes, accounting for 1-2% of the total polyadenylated RNA after stimulation (6) . The concentrations of gram-negative bacterial endotoxin or toxic shock syndrome toxin from Staphylococcus aureus that stimulate human IL-1 production in vitro are low (50-500 pg/ml) (7, 8) , and recent data demonstrate that clinically relevant concentrations of purified CSa and CSa desarg also induce human IL-I release (9) .
The production of IL-I becomes an important consideration in many disease processes. Humans are particularly sensitive in that elevated plasma levels can be measured in patients with a variety of febrile diseases (10) , after hemodialysis (1 1) , and in normal human subjects after strenuous exercise (12) or ovulation (10) . In rabbits, IL-has been demonstrated in the circulation as an endogenous pyrogen after the injection of submicrogram amounts of endotoxin, other pyrogenic toxins, or synthetic adjuvants (1) .
There is now considerable evidence that many of the biological and physiological consequences of bacterial sepsis are due to the release and activity ofpolypeptides such as IL-1 and tumor necrosis factor (TNF).' TNF (also known as cachectin) has recently been implicated as a mediator of fatal endotoxin shock (13, 14) . We now report that IL-I (beta or alpha), which shares no amino acid homology with TNF, induces hypotension and several hemodynamic and hematological parameters characteristic of septic shock. The hemodynamic alterations caused by IL-I seem to require cyclooxygenase products. Because IL-I and TNF are both produced in animals and humans exposed to endotoxins, we also studied the effect of the combination of IL-1 and TNF in the rabbit model; the dramatic hemodynamic and histological changes induced by the combination of these cytokines were also prevented by pretreatment with a single injection of the cyclooxygenase inhibitor, ibuprofen.
Methods
Rabbit model. The rabbit was used in the present studies because its sensitivity to the pyrogenic and metabolic effects of endotoxins are similar to those of human subjects (15) , and also because rabbits respond to human IL-1. Female New Zealand rabbits (5 bolus injection. Using '251I-labeled IL-1, the plasma half-life was -6 min as measured previously (20) . Associated with the fall in arterial blood pressure was a dramatic decrease in SVR (-38±1.8%). By ANOVA analysis to t = 0 min, the significance of the fall in SVR was: t = 10 to t = 110min, P <0.01; t = 120 tot = 150 min, P< 0.05. CVP fell while CO and heart rate (HR) increased, and these reached similar levels of significance during these times. After reaching maximal change (60-80 min), these parameters also steadily returned towards preinjection levels. A bolus injection of IL-l (alpha) (5 ,g/kg) in two rabbits produced similar results (data not shown). We next pretreated three rabbits with an intravenous injection of ibuprofen. After 15 min, during which time there were no significant changes in hemodynamic parameters, the IL-1-induced hypotension was averted (Fig. 1 C) . The change in MAP for this group (-9.4±2.4%) was not significant (P > 0.05) from baseline measurements, nor were the changes in other hemodynamic parameters.
Effect ofa bolus injection ofIL-I followed by constant infusion ofthe cytokine. In order to more closely simulate a clinical situation of infection or injury, in which IL-I production is likely sustained for several hours, rabbits were given a bolus injection followed by a 2-h infusion of IL-1. Initial studies indicated that a bolus injection of 1 gg/kg, followed by 5 ng/kg per min constant infusion for 2 h did not affect any hemodynamic parameter. We doubled this dose and as depicted in Fig.  2 A, a small decrease in MAP was observed (-8%±1.8 at t = 90 min, P < 0.01) in rabbits given an IL-1 bolus injection of 2 ,ug/kg followed by a constant infusion of 10 ng/kg per min.
During this time, peripheral white blood cells (WBC) and platelets decreased. When the dose of the bolus injection and constant infusion was increased 2.5-fold (to 5 ,ug/kg bolus followed by 25 ng/kg per min), hypotension was sustained (Fig. 2   B) . The MAP was depressed for 90 min and began to slowly increase 40 min after the infusion was stopped. The hypotension was maximal 90-120 min after the injection. The fall in MAP was significant, from t = 50 to t = 180 min (P < 0.01) when compared with either the values of the saline control at the same time point or the preinjection values. The maximal fall (-33.1+2.1%, P < 0.01) occurred 100 min after the IL-1 injection and initiation of the infusion. Changes in HR, CO, SVR, and CVP were similarly sustained and significant (P < 0.01). During this time, peripheral leukocyte and platelet counts fell (-75±1.3% and -33±4.7%, respectively, at 120 min).
We repeated these experiments in another group of rabbits, and observed the same changes in WBC and platelet counts, as well as hemodynamic changes. However, the hemodynamic changes were reversed by a single injection of ibuprofen administered at the midpoint of the IL-I infusion (Fig. 2 C) . Despite the continued infusion of IL-1, blood pressure, SVR, and CVP abruptly began to rise, and CO fell towards baseline. Although the reversal of hemodynamic changes took place within 10 min after the injection of ibuprofen, leukocyte and platelet counts remained low for the 3-h period.
During the constant infusion experiments, there was no evidence of hemoconcentration as measured by the hematocrit. When compared with control rabbits receiving saline, IL-1-treated rabbits required no further doses of anesthetic (mean dose 50 mg/kg ketamine for control group vs. 10 mg/kg for all IL-I groups). This observation is consistent with the fact During the infusion, the mean maximal percent changes for MAP, GO, SVR, and HR were -33±1.7 (P < 0.01), +49.5d±4.1 (P < 0.05), -49.9±1 (P < 0.01), and + 19.9±3.6 (P < 0.05), respectively. The maximal mean change in CVP was -3.3±0.5 mmHg (P < 0.05). (C) The effect of intravenous ibuprofen in three rabbits at the mid-point of the infusion. The mean maximal percent changes for MAP, GO, SVR, and HR before the injection of ibuprofen were -33.4± 1.4 (P < 0.01), +37.1± 1.1 (P < 0.01), -48.4± 1.2 (P < 0.01) and + 19.9±3.6 (P < 0.05), respectively. The maximal mean change in GVP was --!2.7±0.3 (P < 0.05). The platelet and WBC counts are shown at the times indicated.
that IL-I increases hourly slow-wave sleep in rabbits and competitively inhibits the binding of opioids to brain synaptosomes in vitro (21, 22) . Ibuprofen treatment (either before or during IL-I infusions) had no effect on this finding.
Effect of TNF in the rabbit model. Previous studies have established that recombinant human IL-1-beta and recombinant human TNF are equipotent as endogenous pyrogens when assayed in rabbits (19) . We next administered TNF to compare the hemodynamic effects of this cytokine in our rabbit model. As shown in Fig. 3 A, a single bolus injection of TNF at 1 ,ug/kg followed by a constant infusion of 5 ng/kg per min had no effect on hemodynamic parameters. In contrast, a single bolus injection of 5 ,ug/kg (Fig. 3 B) induced sustained hypotension, decreased SVR, decreased CVP, and elevated HR and CO (P < 0.01 for all parameters). The hemodynamic effects of this single injection of TNF were comparable with those observed with a bolus injection of IL-1 (5 ,ug/kg) plus a constant infusion at 25 ng/kg per min (compare Fig. 2 B with  Fig. 3 B) . Because this bolus dose of TNF induces circulating levels of IL-1 in rabbits (19), we speculated that the sustained shock-like state induced by a single dose of TNF might be the result of the combination of TNF itself plus IL-1 induced by TNF in these rabbits.
Synergism ofIL-I and TNF in producing a shock-like state and its prevention by intravenous ibuprofen. As shown above in Fig. 4 B, pretreatment prevented the development ofthe shock-like state, despite the fact that the cytokines were also infused for the next 2 h. The WBC and platelet counts were evaluated in these studies. As shown in Figs. 5 A and B, similar to the hemodynamic effects, the combination of the two cytokines produced the greatest decreases compared with control values (P < 0.01). Pretreatment with intravenous ibuprofen prevented the combination cytokine-induced decreases in WBC and platelets. WBC counts of rabbits receiving saline control or low-dose TNF rose with time. One possible explanation for these increases is that the rabbits were stressed by the preexperiment catheter placements or other stressful aspects ofthe procedure.
Tissue studies. After each experiment (180 min after the cytokine injection), rabbits were killed, the organs were examined, and various tissues were fixed. Gross changes were observed only in the lungs. The lungs of control rabbits receiving saline appeared pink with occasional areas of subpleural blood (1.5-2 mm diam). The lungs of rabbits receiving low doses of either cytokine showed larger (0.5-1 cm diam) areas of hemorrhage on the pleural surface, particularly in rabbits injected with 1 utg/kg of TNF. In contrast, the lungs of rabbits receiving the combination of IL-1 plus TNF appeared liver-like upon inspection and palpation. This comparison is shown in Fig. 6 . In rabbits pretreated with ibuprofen before the combination of cytokines, the lungs showed diffuse surface hemorrhage, but gross hepatization was absent and the lungs were clearly less severely affected than the lungs of rabbits not given ibuprofen. The gross findings were consistent with the histological sections in the various treatment groups. Figs. 7 A-E illustrate the microscopic findings. Figure 7 A illustrates the lung of a rabbit used for saline control experiments. The microscopic appearance of lungs from rabbits receiving low-dose IL-1 (2 ,ug/kg and 10 ng/kg per min infusions) showed only an occasional granulocyte (rabbit neutrophils appear eosinophilic) in the alveolar capillary bed (Fig. 7 B) . In contrast, in the lungs of rabbits given low-dose TNF, there was evidence of red blood cells and granulocytes in the alveolar space and increased numbers ofgranulocytes in the capillaries (Fig. 7 C) . Fig. 7 D is from a rabbit that received the combination of cytokines. The alveolar space is full of protein, red blood cells, and WBC. The effect of ibuprofen pretreatment of rabbits receiving IL-1 plus TNF is shown in Figure 7 E. The massive transudate is absent, but cellular infiltration can still be observed.
Discussion
Animal models for the induction of septic shock usually employ large (,ug-mg/kg) doses of endotoxins or live organisms, and that under these conditions, IL-1 and TNF are produced. Although TNF induces shock in rats (14, 23) , the present studies demonstrate that IL-1 is also capable of inducing hypotension and hemodynamic changes typical of shock in rabbits. The onset, maximal effect, and resolution of hypotension induced by a single bolus injection of IL-l is nearly identical to the time course ofthe pyrogenic response to one-tenth the dose (17) . IL-1 causes fever by its ability to increase AA metabolites from the specialized vascular endothelial organs ofthe laminia terminalis of the hypothalamus (24) (25) (26) . It seems likely that the vascular endothelium is also the target for IL-1 in the pathogenesis of hypotension. This is supported by evidence that IL-1 induces increased endothelial cell production of PGE2, PGI2, and platelet activating factor (27) (28) (29) ; in addition, IL-1 induces increased neutrophil and macrophage thromboxane B2 (TXB) release (30) . A sudden increase in some of these substances may induce leukocyte aggregation and systemic vasodilation, which would account for the dramatic decrease in SVR observed in our studies. Experiments have shown that IL-1 stimulates endothelial cell-leukocyte adhesion (31), and in addition to TXB production, this may explain the rapid drop in leukocyte counts. This is supported by the large accumulation of neutrophils adhering to the lung endothelium, that has been observed after IL-1 injected into rabbits (32).
One goal of the present study was to compare the IL-l-induced hemodynamic changes with those induced by recombinant human TNF in the same animal model. In recent studies using pentobarbital-anesthetized dogs, a dose of human TNF of 10 ,ug/kg produced a reversible 30% fall in MAP (33) ; this is nearly 50 times less than the amount of TNF required to produce hypotension in rats (14) . Although the fever-producing ability of human IL-1 or TNF in rabbits is similar on a weight basis (19) a sustained shock-like state in our model and was clearly more potent than the same dose of IL-1. However, since the amount of TNF employed in these studies induces circulating IL-1 in rabbits (19) , we speculate that the sustained shock-like state after a single injection of TNF might be due to a combination of TNF and IL-1. This is supported by studies demonstrating the induction of IL-1 from human monocytes (18) and from cultured endothelial cells (34) (particularly doses that induce IL-I in vivo) may be, in part, due to the combined effect of TNF plus IL-1. Recent studies support the concept that IL-I and TNF act synergistically in a variety of biological assays for these cytokines (35, 36) . Relevant to the present study is the finding that IL-I and TNF act synergistically on fibroblast PGE2 production (37) and endothelial cell damage (35) . A role for cyclooxygenase products and platelet activating factor in the development of septic shock is well-founded in animal models (38) (39) (40) (41) and studies in humans (42) ; hence, we studied the effects of cyclooxygenase inhibition in our model. A single intravenous injection of ibuprofen prevented the IL-l-and IL-l/TNF-induced hemodynamic changes. Moreover, ibuprofen reversed the shock-like hemodynamic parameters sustained during constant infusions ofIL-1. The ability of ibuprofen to avert hemodynamic effects supports the notion that IL--and TNF-induced increases in cyclooxygenase products contribute significantly to the hemodynamic changes observed. In a variety of models of septic shock, ibuprofen attenuates the increased levels of TXB, PGI2, and PGE2, as well as hemodynamic changes associated with the shock (43) (44) (45) (46) . These latter studies suggest that the AA metabolites mediating endotoxin-and cytokine-induced hypotension are similar.
Examination of various tissues (kidney, skin, intestines, liver, and spleen) revealed that the lung was the only organ that was substantially affected by the cytokine infusions in the doses used in these studies. TNF appeared to induce more gross and microscopic lung damage than IL-1; however, the combination of both cytokines produced a dramatic effect, with massive accumulation of protein and cells in the alveolar space. The hemorrhage and hepatization which were observed with the combination of low doses of both cytokines suggest that IL-l and TNF act together in disrupting the pulmonary vascular endothelium, as has been shown recently in endothelium of the skin (35) . Like the hemodynamic effects, the gross and microscopic changes were significantly ameliorated by pretreatment with a single injection of ibuprofen. The IL-1-and IL-l/TNF-induced leukopenia and thrombocytopenia was also prevented by ibuprofen. These findings are consistent with experiments showing that ibuprofen reduces neutrophil adherence and responses to chemotactic factors (47, 48) . This fall in WBC has also been observed in humans during recent studies in which 2-3 ug/kg of intravenous TNF induces a sudden decrease in circulating neutrophils, as well as fever and hypotension (49 
